Distinguished Professor of Ophthalmology, University of California, San Francisco
Managing Partner, ForSight Labs
Ophthalmology, Drug Delivery, Early Stage Company Development
EDUCATION
BS – Emory University
MS – University of Alabama in Birmingham
MD – University of South Alabama
AWARDS AND ACCOLADES
Lifetime Achievement Award. American Academy of Ophthalmology, 2015
Industry Innovator of the Year Award (OIS)
Catalyst Award, Glaucoma Research Foundation, 2017
Heed-Gutman Award, The Society of Heed Fellows, 2000
COMPANIES AND BOARDS
Co-Founder: Azura, Second Sight (NASDAQ:EYES), InnoRx (acquired by Surmodics), NeoVista (acquired by Orya), Retina Lab (acquired by Iridex), Transcend Medical (acquired by Novartis), ForSight VISION 1- 6: ForSight VISION 2 (acquired by QLT), ForSight VISION 4 acquired by Genentech/Roche), ForSight VISION5 (acquired by Allergan)
Board of Directors: Sprial Therapuetics, ForSight Vision 6, Presby, Voyant, Nexis Vision, Inc. (formerly ForSight VISION3)
